Laparoscopic versus open total gastrectomy for clinical stage I gastric cancer: Morbidity and mortality results from a prospective randomized multicenter controlled trial (CLASS02)

MLA

Gang Zhao, et al. “Laparoscopic versus Open Total Gastrectomy for Clinical Stage I Gastric Cancer: Morbidity and Mortality Results from a Prospective Randomized Multicenter Controlled Trial (CLASS02).” Journal of Clinical Oncology, vol. 38, Feb. 2020, p. 378. EBSCOhost, https://doi.org/10.1200/jco.2020.38.4_suppl.378.

APA

Gang Zhao, Hua Huang, Yihong Sun, Naiqing Zhao, Zekuan Xu, Jian Suo, Haojie Li, Fenglin Liu, Chang-Ming Huang, Hongyong He, Jiankun Hu, Yong Li, Jianxin Ye, Xiaohui Du, Xiangqian Su, Peiwu Yu, Guoxin Li, & Wei Zhang. (2020). Laparoscopic versus open total gastrectomy for clinical stage I gastric cancer: Morbidity and mortality results from a prospective randomized multicenter controlled trial (CLASS02). Journal of Clinical Oncology, 38, 378. https://doi.org/10.1200/jco.2020.38.4_suppl.378

Chicago

Gang Zhao, Hua Huang, Yihong Sun, Naiqing Zhao, Zekuan Xu, Jian Suo, Haojie Li, et al. 2020. “Laparoscopic versus Open Total Gastrectomy for Clinical Stage I Gastric Cancer: Morbidity and Mortality Results from a Prospective Randomized Multicenter Controlled Trial (CLASS02).” Journal of Clinical Oncology 38 (February): 378. doi:10.1200/jco.2020.38.4_suppl.378.